Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DW-116

Known as: DW 116 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
  • J. C. Kim, S. H. Kim, +6 authors M. Chung
  • Journal of applied toxicology : JAT
  • 2005
  • Corpus ID: 32738694
DW‐116 is a newly developed fluoroquinolone antibacterial with a broad spectrum against both Gram‐positive and Gram‐negative… Expand
2003
2003
DW-116 is a newly developed fluoroquinolone antibacterial with a broad spectrum against both gram-positive and gram-negative… Expand
2003
2003
We have recently reported that the fluoroquinolone antibacterial DW-116 induces a significant developmental toxicity in rat. The… Expand
2003
2003
The purpose of this study is to investigate the potential subchronic toxicity of DW-116 by a 26-week repeated oral dose in… Expand
2003
2003
We investigated maternal and fetal tissue distribution of DW-116, a newly developed fluoroquinolone with a broad antibacterial… Expand
2000
2000
Abstract DW-116, 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-l-piperazinyl)-1, 4-dihydro-4-oxoquinolone-3-carboxylic acid… Expand
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • table 2
1998
1998
The safety, tolerability and pharmacokinetics of DW-116, a new fluoroquinolone with a broad antibacterial spectrum, were… Expand
  • table I
  • figure 1
  • table II
  • table III
  • table IV
1997
1997
DW-116 is a novel fluoroquinolone that was two- to four-fold more active than rufloxacin and less active than sparfloxacin… Expand
1997
1997
The metabolic disposition of the new fluoroquinolone antibacterial agent DW116 has been studied in Sprague-Dawley rats. The… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1997
1997
The objectives of this study were to characterize the pharmacokinetics of 1-5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1… Expand